Purpose: To prospectively evaluate and compare the junctional zone (JZ) and outer myometrial thickness in infertile and healthy nulliparous women at different locations in the uterine wall during the menstrual cycle by magnetic resonance imaging (MRI). Materials and Methods: We performed pelvic 1.5T MRI (T 2 -weighted turbo spin echo sequences) on 28 infertile women: 5 with infertility of unknown origin, 12 anovulating, and 11 on ovarian stimulation therapy (mean age 28.5, 30.8, and 29.3 years, respectively); and a control group consisting of 18 healthy nulliparous volunteers (mean age 26.4 years). The women with unknown infertility origin and the control group underwent MRI investigations during their follicular, ovulatory, and luteal phase. The JZ and outer myometrial thicknesses were measured at six locations in the uterine wall: anterior and posterior wall of the isthmus, midcorpus, and fundus. Results: The JZ in the anovulating women at the posterior wall of the isthmus (4.2 mm) was significantly thicker compared to the control group (3.2, 3.0, and 2.9 mm, in respectively the three menstrual phases) (P 5 0.027). The outer myometrium in the anovulating women was significantly thicker at all measured locations (average 11.5 mm) in comparison to the control group (8.1, 8.0, and 8.5 mm, in respectively the three menstrual phases) (P < 0.050). The infertile women on ovarian stimulation therapy showed a significantly thicker outer myometrium at the anterior wall (isthmus, midcorpus, and fundus) (P < 0.050).
I
nfertility has a prevalence of 14% in the general population.
1,2 A female underlying cause is involved in about twothirds of cases. In 15-30% of infertile couples, the underlying cause of infertility is not identified after completion of standard fertility tests (eg, tests to investigate ovulatory disorders, tubal damage, uterine or peritoneal problems, and male factors). 2 The uterine junctional zone (JZ) plays an integral part in many reproductive functions. 3 The JZ, also called the archimyometrium or the stratum subvasculare, is the inner third of the myometrium and is hence located at the interface between endometrial mucosa and outer myometrium. 3 It is a hormone-dependent structure represented by the presence of cyclic changes in immunoreactive estrogen and progesterone receptor expression throughout the menstrual cycle, comparable with the changes observed in the endometrium. 3, 4 The major function of the JZ during the reproductive period of women is directing sperm transport into the tube ipsilateral to the dominant follicle, which is provided by JZ uterine peristalsis. [5] [6] [7] Furthermore, it is proven that an optimal JZ thickness is important in embryo implantation. A thickened uterine JZ on magnetic resonance imaging (MRI) is a failure predictive factor for embryo implantation in in vitro fertilization (IVF) attempts. 8, 9 Thus, their might be an association between abnormalities of the JZ and sub-or infertility. Several studies have reported a link between infertility and various gynecological disorders involving the JZ, such as adenomyosis, endometriosis, and leiomyomas. [10] [11] [12] Despite these associations, the exact role of this zone in infertility is still unclear.
The standard imaging method to visualize the JZ and to discriminate it from the adjacent zones is pelvic MRI, as first described by Hricak et al. 13 On T 2 -weighted MR images, the JZ is presented as a low signal-intensity zone sandwiched between the high signal-intensity endometrium and the medium signal-intensity outer myometrium. [13] [14] [15] The aim of the present study was to analyze and compare the JZ thickness, outer myometrial thickness, and the ratio of JZ versus total myometrial thickness in healthy nulliparous women and in infertile women during their menstrual cycle and at different locations in the uterine wall by MRI. We hypothesized that the JZ is thicker in infertile women.
Subjects and Methods
The study protocol and informed consent were approved by the local hospital Ethics Committee (registration number 056).
Study Population
In this prospective study, 18 healthy nulliparous volunteers and 28 infertile women were included over a recruitment period of 50 months (from December 2007 to January 2012). The healthy nulliparous volunteers had no history of infertility and were not taking hormonal contraception (control group, mean age 26.4 years). The healthy nulliparous women were recruited by contacting coworkers from our hospital, students, and PhD students from the local university, personal contacts, and by cooperation with outside physicians. The infertile patients were referred for participation in this study by our hospital infertility center. Exclusion criteria were age less than 18 years or more than 35 years, non-Caucasian origin, women with a pacemaker, clips, or other MRI-incompatible implanted devices, pregnancy, diminished renal function (assessed by creatinine levels collected prior to MRI investigation), medical history of infertility or a gynecological disorder such as a bleeding disorder or an irregular menstrual cycle (for the control group), and previous unknown uterine morphologic abnormality found on the first MRI examination. All women provided a written informed consent and filled out an epidemiological questionnaire in order to obtain information concerning their birth date, height, weight, age at menarche, and whether or not they currently smoke.
The infertile patients were subdivided into three groups based on the underlying cause of their infertility and whether or not they were on ovarian stimulating therapy: 5 women with unexplained infertility (mean age 28.5 years), 12 anovulating women (mean age 30.8 years), and 11 women on ovarian stimulation therapy (Table 1 ) (mean age 29.3 years).
Blood Laboratory Tests
Blood samples were collected prior to each MRI examination in order to assess the levels of human chorionic gonadotrophin (hCG), creatinine, follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol, and progesterone. The follicular phase was considered around day 6-13 of the menstrual cycle, the ovulatory phase around day 14-16, and the luteal phase around day 17-28. The exact phase of the menstrual cycle was determined based on the hormone levels.
MRI
The 18 healthy nulliparous women were scheduled to undergo MRI investigations during three phases of their menstrual cycle: follicular (n 5 17), ovulatory (n 5 17), and luteal (n 5 16) phase. Due to practical considerations, one woman underwent MRI only during her follicular phase, one woman during her follicular and ovulatory phase, and one woman during her ovulatory and luteal phase. This resulted in a total of 50 MRI examinations in the healthy nulliparous women. The five women with unexplained infertility were also subjected to MRI examinations during the follicular (n 5 4), ovulatory (n 5 3), and luteal (n 5 5) phases. One woman underwent MRI only during her follicular and luteal phase and one woman only during her luteal phase, resulting in 12 MRI examinations in total. MRI was performed on a random day during the menstrual cycle for the anovulating women (n 5 12) and for the infertile women who used ovarian stimulation therapy (n 5 11) (Fig. 1) .
MRI investigations were obtained with a 1.5T magnet unit (Siemens Magnetom Symphony Tim (4G-Dot upgraded), Siemens, Erlangen, Germany; Software Syngo MR B15). An intravenous catheter was inserted in the elbow crease of the women before they were positioned in head-first/supine position. An eight-channel receive-only body array was placed on the pelvis. T 2 -weighted turbo spin echo (T 2 TSE) sequences in three different planes were acquired: transversal, coronal, and sagittal plane (Table 2) . Then, in agreement with the woman, the abdominal-specific antispasmodic Hyoscine Butylbromide (buscopan, 1 ml, 20 mg/ml, Boehringer Ingelheim, Germany), diluted in sodium chloride (10 ml, 0.09%, Baxter, Lessines, Belgium) was manually injected in order to reduce bowel peristalsis. Afterwards, sagittal T 2 TSE images without fat suppression were obtained. All images were sent to a dedicated workstation.
Image Analysis
The measurements were performed on a specialized workstation (MMWP, Syngo MMWP VE36A) using the measuring cursor included in the workstation's software. All measurements were completed by two independent investigators, a radiologist with 13 years of experience in pelvic imaging and an intern in radiology with 3 years of pelvic MRI experience. Examinations were evaluated consecutively and both investigators were blinded for the clinical information of the women. The T 2 TSE images in transversal, coronal, and sagittal plane before buscopan injection of the healthy nulliparous women were first analyzed by the radiologist in order to detect possible suspicious findings of congenital or acquired uterine abnormalities.
The corpus size latero-lateral (transverse or LL) was measured on the transversal T 2 TSE image obtained before buscopan injection (Fig. 2A) . The sagittal T 2 TSE image after buscopan injection was used in order to measure the corpus length and the anteroposterior (AP) uterus size (Fig. 2B ). The volume of the corpus uteri was subsequently calculated using the formula for an ellipsoid: length 3 height (AP) 3 width (LL) 3 0.523. 16 The sagittal T 2 TSE image after buscopan injection was also used to measure the JZ and outer myometrial thickness at six different uterine wall locations. The six locations at which these thicknesses were measured are the anterior and posterior wall at the level of the isthmus, the middle (midcorpus), and the fundus (Fig. 2C,D) . According to this method, both the anterior and posterior uterine wall were divided into three parts equally in length. Subsequently, the JZ and outer myometrial thickness were measured at the central point in each part. The ratio of JZ thickness versus total myometrial thickness was calculated as well. It was calculated by dividing the thickness of the JZ by the corresponding thickness of the total myometrium at the same location (ratio 5 JZ thickness/ (JZ thickness 1 outer myometrial thickness)).
The average JZ thickness, outer myometrial thickness, and ratio of JZ versus total myometrial thickness were calculated as the average of the six measurements of every woman in the group. Fat suppression -----
Statistical Analysis
All statistical analyses were performed by means of the computer program SAS v. 9.4 (Cary, NC). A significance level of 5% was used. No correction for multiple testing was applied. Cohen's kappa coefficient was calculated in order to evaluate the concordance between the two investigators. Moreover, we investigated using linear mixed models, whether the thickness of the JZ and outer myometrium were correlated with uterine volume, age at menarche, smoker/nonsmoker, and length and height of the women.
Linear mixed models were used in order to investigate the effect of infertility, the effect of the location in the uterine wall, and the effect of menstrual phase (for the control group) on the JZ thickness, on the outer myometrium thickness, and on the ratio of JZ versus total myometrial thickness. The first statistical model investigated the effect of the menstrual phase in the control group and included two fixed effects and their interaction. The fixed effects were the menstrual phase and the location in the uterine wall. The second statistical model also included two main fixed effects and their interaction. The first fixed effect comprised the effect of the group and the second fixed effect was the location in the uterine wall. The association between measurements of the same woman (eg, JZ thickness measured in the three menstrual phases) was incorporated by means of a random intercept at the woman level. A parsimonious model was obtained by backward elimination of the interaction terms not statistically significant at a 5% level of significance. In order to normalize the data, statistical analyses were performed on the natural log-transformed outcome data.
Results
No congenital or acquired uterine abnormalities were found in the healthy nulliparous women. The JZ and outer myometrium thickness were identified and measured in each woman. Both investigators show high agreement, as Cohen's kappa equaled 0.87. There were no correlations between the JZ and outer myometrial thickness with uterine volume, height, and weight of the women, age at menarche, and smoker/nonsmoker (P > 0.050).
FIGURE 2: Measurements of the corpus uteri volume, the junctional zone thickness, and outer myometrium thickness, assessed on T 2 -weighted turbo spin echo magnetic resonance images. A: The transversal image obtained before buscopan injection was used to measure the corpus size latero-lateral (LL). B: On the sagittal image after buscopan injection without fat suppression, the length and the anteroposterior (AP) uterus size were measured. C,D: The same sagittal image was also used to measure the junctional zone (C) and outer myometrium (D) thickness. According to the measuring method, the uterine walls were divided into three parts equally in length (blue lines), and the measurement was performed at a central point in each part. PF: posterior wall at the fundus; PM: posterior wall at the midcorpus; PI: posterior wall at the isthmus; AF: anterior wall at the fundus; AM: anterior wall at the midcorpus; AI: anterior wall at the isthmus.
JZ Thickness
The JZ thickness measurements and the mean for the six uterine wall locations, for each group and per menstrual cycle phase, are displayed in Fig. 4 . Table 3 shows the median, minimum, and maximum JZ thickness per location and the average JZ for each group and menstrual phase.
The average JZ in every group of infertile women was slightly thicker than in healthy nulliparous women (Fig. 3) . However, only the JZ in the anovulating women at the posterior wall of the isthmus was significantly thicker than the JZ at the corresponding location in the healthy nulliparous women (P 5 0.027). FIGURE 4: Junctional zone thickness measurements in the control group and in three groups of infertile women at six locations in the uterine wall during the menstrual cycle, assessed on T 2 -weighted turbo spin echo MR images. The control group (group 1) consists of healthy nulliparous women without infertility history. The three groups of infertile women are women with unexplained infertility (group 2), anovulating women (group 3), and infertile women using ovarian stimulation therapy (group 4). Every dot represents the junctional zone thickness in one woman, the small line represents the average thickness for each group. Data analysis was performed on the natural log-transformed data. F: follicular phase; O: ovulatory phase; L: luteal phase; P < 0.050 for group 3.
Furthermore, the different uterine wall locations show no significant differences in JZ thickness, in every group (anterior and posterior wall of the isthmus, midcorpus, and fundus) (P > 0.050).
In the healthy nulliparous women, the JZ thickness was not significantly different between the three menstrual phases, for each measured location in the uterine wall (P > 0.050). In women with unexplained infertility, a decrease in JZ thickness can be observed in the ovulatory phase, followed by an increase in the luteal phase, especially at the anterior wall at the level of the isthmus and midcorpus. Statistical analysis of the significance of this difference was not possible due to the low number of subjects in this group.
Outer Myometrial Thickness
The outer myometrial thickness measurements for each group, menstrual phase, and uterine wall location are shown in Fig. 5 and the median, minimum, and maximum thickness and averaged over each assessed location are listed in Table 4 . Statistical analysis revealed that the outer myometrium in anovulating women was significantly thicker than in healthy nulliparous women, at each measured uterine location (P < 0.005). The infertile women on ovarian stimulation therapy also demonstrated a thicker outer myometrium than healthy nulliparous women at the anterior wall of the level of the isthmus (P 5 0.015), midcorpus (P 5 0.012), and fundus (P 5 0.047). Although the The junctional zone thickness was measured during three menstrual phases: follicular, ovulatory, and luteal phase; and at six locations in the uterine wall: anterior and posterior wall of the isthmus, midcorpus, and fundus. The average represents the mean thickness over all locations. Data represents minimum, median, and maximum measurement. P (control): P-value concerning the group of interest and the control group by means of linear mixed model analysis; p (anovulating women): P-value concerning the group of interest and the anovulating women by means of linear mixed model analysis; *statistical significance at 5% significance level.
difference did not reach statistical significance, there was a trend towards a thicker outer myometrium in the infertile women on ovarian stimulation therapy compared to the healthy nulliparous women at the posterior wall of the midcorpus (P 5 0.061) and fundus (P 5 0.052). Observation of the data of the women with unexplained infertility showed that the average outer myometrium was thinner than in the other two infertile participant groups. In each group, the outer myometrium at the level of the isthmus in both walls was significantly thinner than at the midcorpus and fundus in both walls (P < 0.050). In addition, in the group of the anovulating women, the outer myometrium at the posterior midcorpus was significantly thicker than at the posterior fundus (P 5 0.046).
No differences in outer myometrial thickness were seen between the menstrual phases (P > 0.050) in healthy nulliparous women, for each uterine location, and empirically, this was also valid for women with unexplained infertility. Figure 6 displays the individual ratios of JZ versus total myometrial thickness for each group at the six uterine wall locations. The median, minimum, and maximum ratios per uterine wall location and the averaged ratio per group and menstrual phase are listed in Table 5 . The ratios were not significantly different between the healthy nulliparous women and the infertile groups, for each location in the uterine wall. The ratio of women with unexplained infertility was notably higher than that of healthy nulliparous women and other infertile participating groups.
Ratio of Junctional Zone Versus Total Myometrial Thickness
The ratios calculated at the six uterine wall locations were significantly different from each other. For healthy nulliparous women, the ratio calculated at the anterior and posterior wall of the isthmus was significantly higher than at the anterior wall of the midcorpus (P < 0.001) and fundus (P 5 0.017 and P 5 0.002, respectively) and higher than at the posterior wall of the midcorpus (P < 0.001) and fundus (P 5 0.003 and P < 0.001, respectively). For the anovulating women, the ratio assessed at the anterior and posterior wall of the isthmus was higher than at the anterior (P 5 0.014 and P 5 0.003) and posterior (P 5 0.006 and P 5 0.001) wall of the midcorpus and the ratio at the posterior wall of the isthmus was also significantly higher than the anterior (P 5 0.017) and posterior (P 5 0.017) wall of the fundus. For infertile women on ovarian stimulation therapy, the anterior wall of the isthmus had a significantly higher ratio than the anterior wall of the midcorpus (P 5 0.028) and fundus (P 5 0.009) and the posterior wall of the fundus (P 5 0.050) and the posterior wall of the isthmus had a significantly higher ratio than the anterior and posterior wall of the midcorpus (P 5 0.006 and P 5 0.038, respectively) and fundus (P 5 0.002 and P 5 0.012, respectively)).
During the menstrual cycle, no differences in the ratios were determined between the follicular, ovulatory, and luteal phase in healthy nulliparous women (P > 0.050). Comparing the ratios of the different menstrual phases in women with unexplained infertility, no difference was noticed.
FIGURE 5: Outer myometrial thickness measurements in the control group and in three groups of infertile women at six locations in the uterine wall during the menstrual cycle, assessed on T 2 -weighted turbo spin echo MR images. The control group (group 1) consists of healthy nulliparous women without infertility history. The three groups of infertile women are women with unexplained infertility (group 2), anovulating women (group 3), and infertile women using ovarian stimulation therapy (group 4). Every dot represents the outer myometrial thickness in one woman, the small line represents the average thickness for each group. Data analysis was performed on the natural log-transformed data. F: follicular phase; O: ovulatory phase; L: luteal phase; *P < 0.050 for group 1; P < 0.050 for group 3; P < 0.050 for group 4; : P < 0.100 for group 4.
Discussion
This study showed that the JZ thickness in anovulating women at the posterior wall of the isthmus is significantly thicker than in healthy nulliparous women.
The outer myometrial thickness is also thicker in anovulating women at each assessed location (anterior and posterior wall of the isthmus, midcorpus, and fundus) and in infertile women taking ovarian stimulation therapy in the context of assisted reproductive therapy at the anterior uterine wall (at the level of the isthmus, the midcorpus, and the fundus).
These findings imply that the thickness of the JZ and outer myometrium can best be measured at the anterior wall of the uterus in order to detect the largest differences between "fertile" and each group of infertile women.
Our study found no differences in JZ thickness, in outer myometrial thickness, or in the ratio of JZ versus total myometrial thickness between the follicular, ovulatory, and luteal phase in healthy nulliparous women. These results regarding the JZ thickness 17, 18 and the outer myometrial thickness 18 were in concordance with previous studies.
However, Haynor et al 19 demonstrated significant changes in myometrial thickness throughout the menstrual cycle, with increasing thickness during the follicular phase followed by a significantly dropped increase during the luteal phase. They investigated six healthy women twice a week The outer myometrial thickness was measured during three menstrual phases: follicular, ovulatory, and luteal phase; and at six locations in the uterine wall: anterior and posterior wall of the isthmus, midcorpus, and fundus. The average represents the mean thickness over all locations. Data represents minimum, median, and maximum measurement. P (control): P-value concerning the group of interest and the control group by means of linear mixed model analysis; p (anovulating women): P-value concerning the group of interest and the anovulating women by means of linear mixed model analysis; *statistical significance at 5% significance level.
during one full menstrual cycle. That study contradicts our findings. However, the healthy nulliparous women of our study were investigated only once during the follicular, ovulatory, and luteal phase. Based on the results of our study, we conclude that the woman's menstrual phase, during which the MRI investigation was executed, does not affect the thickness of the JZ and outer myometrium significantly. A thickened JZ has generally been related to inner myometrium adenomyosis 15, [20] [21] [22] and is considered a negative predictive factor for in vitro fertilization (IVF) implantation failure. 8, 9 Inner myometrium adenomyosis is a gynecological disorder characterized by benign invasion of basal endometrial stoma and glands into the underlying myometrium. 15, 21 Animal experiments and human studies have suggested that adenomyosis is associated with infertility. 23, 24 The diagnosis of adenomyosis remains difficult because of the lack of a definite consensus classification. Several studies suggested that adenomyosis is strongly suspected when the JZ measures at least 12 mm in thickness on MR images, 15, 20, 21, [25] [26] [27] whereas others concluded that a maximal thickness of 10 mm is considered a cutoff value beyond which JZ adenomyosis is assumed. 10, 28 Hence, the maximum thickness of healthy JZ is still arguable. Another parameter that can be considered in the diagnosis of adenomyosis is the ratio of JZ versus total myometrial thickness, representing the relationship between JZ and myometrial thickness, introduced by Reinhold et al 27 and
Bazot et al. 28 Reinhold et al found a significant difference in this ratio between patients with adenomyosis (69%) and a control group (44%) and defined a maximum ratio of 40% in healthy women. Bazot et al concluded similarly that a ratio higher than 40% allows diagnosis of adenomyosis with a sensitivity of 65% and a specificity of 92%.
The underlying association between adenomyosis and infertility is still not fully understood. The invasion of endometrial stoma and glands into the myometrium in adenomyosis results in surrounding smooth-muscle hyperplasia. 10 It can be postulated that a thickened or an altered morphology of the JZ can reduce uterine peristaltic activity and decrease endometrial receptivity, which affects respectively sperm transport and embryo implantation. 29 Furthermore, Maubon et al 8 and Piver 9 showed a pregnancy failure rate of more than 74% if the average JZ thickness was >7 mm or if the maximal JZ thickness was >10 mm. The incidence of a thickened JZ (defined as an average JZ in anterior, posterior, and fundal wall of at least 7 mm or a maximal JZ thickness of at least 10 mm) was significantly higher in the group of women with unexplained infertility in comparison with the incidence in other subtypes of infertility (male infertility, endometriosis, dysovulation, or tubal abnormalities). 8 In addition, Youm et al 30 concluded that a thickened myometrium (>2.5 cm) in infertile women assessed by transvaginal ultrasonography also exerts overall adverse effects on IVF and embryo transfer outcomes. The infertile women in our study who had no ovulation demonstrated a significantly thicker JZ than the healthy nulliparous women at the posterior wall of the isthmus. These data suggest that the JZ can possibly play a role in the underlying cause of infertility in these women. A thickened JZ could possibly affect the contractility and therefore impede sperm transport or could interfere with embryo implantation. In addition, a significantly thicker outer myometrium was shown at the anterior and posterior uterine wall of the anovulating women and at the anterior wall of the infertile women on ovarian stimulation therapy. This implies that it is likely that the outer myometrium plays a FIGURE 6: Ratio of junctional zone versus total myometrial thickness measurements in the control group and in three groups of infertile women at six locations in the uterine wall during the menstrual cycle, assessed on T 2 -weighted turbo spin echo MR images. The control group (group 1) consists of healthy nulliparous women without infertility history. The three groups of infertile women are women with unexplained infertility (group 2), anovulating women (group 3), and infertile women using ovarian stimulation therapy (group 4). The ratio was calculated by dividing the junctional zone thickness by the total myometrial thickness (ratio 5 junctional zone thickness / (junctional zone thickness 1 outer myometrial thickness). Every dot represents the junctional zone thickness in one woman, the small line represents the average thickness for each group. Data analysis was performed on the natural log-transformed data. F: follicular phase; O: ovulatory phase; L: luteal phase; *P < 0.050 for group 1; P < 0.050 for group 3; P < 0.050 for group 4. role in the underlying cause of their infertility. A thicker JZ or outer myometrium was not noticed in the women with unexplained infertility, which was not as expected, but no definite conclusions can be drawn for this group due to the low number of subjects. Future research could go deeper in the underlying role of the JZ or outer myometrial thickness in infertile women or could focus on other characteristics of the JZ in reproduction such as contractility and perfusion characteristics.
A limitation of this study is the low number of infertile women, especially those with unexplained infertility. The number of this group of women was too low to perform statistical analysis on. These data are included in order to give an overview of all types of infertile women. Another limitation is that not all women underwent three MRI investigations per menstrual cycle.
In conclusion, infertile anovulating women demonstrated a significantly thickened JZ at the posterior wall of the isthmus and a significantly thickened outer myometrium at both the anterior and posterior uterine wall. In infertile women on ovarian stimulation therapy, a thickened outer myometrium was also demonstrated at the anterior uterine wall. These findings suggest that the thickness of the JZ, and more likely the outer myometrium, could possibly be associated with infertility. These results could be used in the context of assisted reproductive therapy in order to attempt to augment the implantation rate. The results need to be confirmed in further studies on a larger series. 
